- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场最近连续上涨中，短期小心回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有121家主力机构披露2025-06-30报告期持股数据，持仓量总计2127.50万股，占流通A股5.32%
- 波段诊断：
-
技术面诊股
诊断结果：8.2技术面打败了95%的股票
技术面评分前10的股票
近期的平均成本为123.81元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为123.81元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"123.81","date":1756799542,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.09.03","stock":"-1.30","trade":"-0.53","ind":"-0.65"},{"date":"2025.09.02","stock":"10.00","trade":"-1.36","ind":"-2.14"},{"date":"2025.09.01","stock":"10.00","trade":"3.19","ind":"1.05"},{"date":"2025.08.29","stock":"1.35","trade":"1.06","ind":"0.99"},{"date":"2025.08.28","stock":"-0.61","trade":"-0.40","ind":"2.25"},{"date":"2025.08.27","stock":"-2.24","trade":"-2.79","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.07","trade":"-0.99","ind":"0.26"},{"date":"2025.08.25","stock":"1.35","trade":"1.41","ind":"2.26"},{"date":"2025.08.22","stock":"-0.15","trade":"-0.02","ind":"2.07"},{"date":"2025.08.21","stock":"0.67","trade":"0.11","ind":"-0.06"},{"date":"2025.08.20","stock":"-0.33","trade":"-0.61","ind":"0.89"},{"date":"2025.08.19","stock":"0.15","trade":"0.81","ind":"-0.12"},{"date":"2025.08.18","stock":"0.84","trade":"1.68","ind":"1.73"},{"date":"2025.08.15","stock":"0.13","trade":"1.22","ind":"1.60"},{"date":"2025.08.14","stock":"-1.46","trade":"-1.28","ind":"-0.87"},{"date":"2025.08.13","stock":"-0.53","trade":"2.24","ind":"1.76"},{"date":"2025.08.12","stock":"-0.36","trade":"-0.91","ind":"0.53"},{"date":"2025.08.11","stock":"-0.49","trade":"1.39","ind":"1.46"},{"date":"2025.08.08","stock":"0.47","trade":"0.26","ind":"-0.26"},{"date":"2025.08.07","stock":"0.64","trade":"-1.51","ind":"-0.18"},{"date":"2025.08.06","stock":"-1.30","trade":"-0.95","ind":"0.64"}]
长春高新,深证成指,生物制品指数
压力支撑
该股压力位为124.13元，支撑位为120.75元。
[{"text":"\u538b\u529b\u4f4d","value":"124.13","date":1756828800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"120.75","date":1756828800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了0%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月03日 20:30
| 机构今日流向(万元) | -1720.87 | 机构5日流向(万元) | -9186.87 |
| 机构10日流向(万元) | -19029.08 | 机构20日流向(万元) | -32953.84 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少13154.42万股，其中基金净减仓36家，主力净减仓277家，请投资者中长期谨慎为宜。
截止2025-06-30，共121家主力机构（基金121家），持仓量总计2127.5万股，占流通A股5.32%
其中，基金持仓与2024-12-31相比：
增仓：17家 ，增持 56.69万股
减仓：53家 ，减持 413.64万股
新出现在主力名单中：42家 ，持有80.5万股
从主力名单中消失：319家 ，原持有12877.97万股
其中，基金持仓与2024-12-31相比：
增仓：17家 ，增持 56.69万股
减仓：53家 ，减持 413.64万股
新出现在主力名单中：42家 ，持有80.5万股
从主力名单中消失：319家 ，原持有12877.97万股
消息面诊股
诊断结果：5.8消息面打败了10%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 长春高新：9月2日获融资买入3.32亿元，占当日流
2025-09-03 - 二连板长春高新：近期经营环境未发生重大变化
2025-09-02 - 长春高新：连续两个交易日收盘价格涨幅偏离值累计达到
2025-09-02 - 长春高新拟赴港上市 加速全球化战略布局
2025-09-02 - 【龙虎榜】 长春高新 9月2日成交明细
2025-09-02 - 9月以来，丽珠、长春高新等超6家药企披露回购股份进
2025-09-02 - 概念动态|长春高新新增“AI智能体”概念
2025-09-02 - 长春高新“入编”中证创新药指数 涨停背后的创新硬实
2025-09-02 - 长春高新2连板！机构：应重新审视公司价值
2025-09-02 - 涨停雷达：半年报落地+创新药+生长激素+国企改革
2025-09-02
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 一般消息 | 高管变动 | 个人工作原因 | 2025-08-14 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派26元(含税) | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 工作安排 | 2024-09-11 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.0行业面打败了93%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.03","price":"-0.65","value":"-0.53"},{"date":"2025.09.02","price":"-2.14","value":"-1.36"},{"date":"2025.09.01","price":"1.05","value":"3.19"},{"date":"2025.08.29","price":"0.99","value":"1.06"},{"date":"2025.08.28","price":"2.25","value":"-0.40"},{"date":"2025.08.27","price":"-1.43","value":"-2.79"},{"date":"2025.08.26","price":"0.26","value":"-0.99"},{"date":"2025.08.25","price":"2.26","value":"1.41"},{"date":"2025.08.22","price":"2.07","value":"-0.02"},{"date":"2025.08.21","price":"-0.06","value":"0.11"},{"date":"2025.08.20","price":"0.89","value":"-0.61"},{"date":"2025.08.19","price":"-0.12","value":"0.81"},{"date":"2025.08.18","price":"1.73","value":"1.68"},{"date":"2025.08.15","price":"1.60","value":"1.22"},{"date":"2025.08.14","price":"-0.87","value":"-1.28"},{"date":"2025.08.13","price":"1.76","value":"2.24"},{"date":"2025.08.12","price":"0.53","value":"-0.91"},{"date":"2025.08.11","price":"1.46","value":"1.39"},{"date":"2025.08.08","price":"-0.26","value":"0.26"},{"date":"2025.08.07","price":"-0.18","value":"-1.51"},{"date":"2025.08.06","price":"0.64","value":"-0.95"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 迈威生物 | 65.94% | 33.03% | 5.7分 |
| 2 | 荣昌生物 | 43.63% | 11.99% | 6.2分 |
| 3 | 欧林生物 | 36.86% | -1.47% | 5.1分 |
| 4 | 我武生物 | 28.67% | 5.27% | 5.6分 |
| 5 | 百普赛斯 | 21.27% | 16.38% | 5.7分 |
| 6 | 西藏药业 | 20.73% | 13.37% | 6.1分 |
| 8 | 长春高新 | 18.58% | 20.31% | 5.9分 |
| 10 | 君实生物 | 12.33% | 6.89% | 5.9分 |
| 12 | 百奥泰 | 8.77% | 10.40% | 5.7分 |
| 14 | ST未名 | 6.92% | 5.31% | 5.1分 |
| 16 | 智翔金泰 | 4.91% | 10.33% | 6.0分 |
| 18 | *ST四环 | 3.04% | 0.42% | 5.0分 |
| 20 | 万泽股份 | 2.17% | 1.17% | 5.8分 |
| 22 | 康辰药业 | 0.19% | 17.84% | 6.5分 |
| 24 | 华兰疫苗 | -0.59% | 1.92% | 5.4分 |
| 26 | 上海莱士 | -2.16% | -3.56% | 4.9分 |
| 28 | 天坛生物 | -3.41% | -1.93% | 4.9分 |
| 30 | 博雅生物 | -4.32% | -3.43% | 5.0分 |
| 32 | 康希诺 | -5.26% | 3.66% | 5.6分 |
| 34 | 康华生物 | -6.06% | -5.68% | 4.8分 |
| 36 | 派林生物 | -6.52% | -3.07% | 4.9分 |
| 38 | 赛伦生物 | -7.32% | -4.79% | 4.8分 |
| 40 | 智飞生物 | -7.43% | -4.43% | 4.3分 |
| 42 | 优宁维 | -7.88% | -4.30% | 5.0分 |
| 44 | 金迪克 | -8.41% | -4.15% | 4.7分 |
| 46 | 凯因科技 | -8.64% | -3.87% | 5.3分 |
| 48 | 康弘药业 | -9.31% | 1.18% | 5.1分 |
| 50 | 科兴制药 | -10.97% | -2.86% | 5.6分 |
| 52 | - | -14.94% | -0.12% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 12/72 ， 14/72。
[{"date":"2025-06-30","value":"4.29","vol":"-0.34"},{"date":"2025-03-31","value":"2.03","vol":"0.63"},{"date":"2024-12-31","value":"11.46","vol":"-0.24"},{"date":"2024-09-30","value":"12.38","vol":"1.37"},{"date":"2024-06-30","value":"7.82","vol":"0.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.29 | 2.03 | 11.46 | 12.38 | 7.82 |
| 行业(%) | -0.34 | 0.63 | -0.24 | 1.37 | 0.72 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"83.35","vol":"68.47"},{"date":"2025-03-31","value":"88.22","vol":"69.78"},{"date":"2024-12-31","value":"85.72","vol":"69.97"},{"date":"2024-09-30","value":"85.60","vol":"70.57"},{"date":"2024-06-30","value":"84.62","vol":"69.89"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
83.35 | 88.22 | 85.72 | 85.60 | 84.62 |
| 行业(%) | 68.47 | 69.78 | 69.97 | 70.57 | 69.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 31/72 ， 39/72。
[{"date":"2025-06-30","value":"-0.54","vol":"7036.72"},{"date":"2025-03-31","value":"-5.66","vol":"6246.12"},{"date":"2024-12-31","value":"-7.55","vol":"48.20"},{"date":"2024-09-30","value":"-2.75","vol":"178.44"},{"date":"2024-06-30","value":"7.63","vol":"19.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.54 | -5.66 | -7.55 | -2.75 | 7.63 |
| 行业(%) | 7036.72 | 6246.12 | 48.20 | 178.44 | 19.75 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-42.85","vol":"5.62"},{"date":"2025-03-31","value":"-44.95","vol":"-7.36"},{"date":"2024-12-31","value":"-43.01","vol":"-10.38"},{"date":"2024-09-30","value":"-22.80","vol":"-53.42"},{"date":"2024-06-30","value":"-20.40","vol":"-9.25"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-42.85 | -44.95 | -43.01 | -22.80 | -20.40 |
| 行业(%) | 5.62 | -7.36 | -10.38 | -53.42 | -9.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 10/72 ， 42/72。
[{"date":"2025-06-30","value":"0.21","vol":"0.14"},{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.44","vol":"0.29"},{"date":"2024-09-30","value":"0.34","vol":"0.22"},{"date":"2024-06-30","value":"0.22","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.10 | 0.44 | 0.34 | 0.22 |
| 行业(次) | 0.14 | 0.06 | 0.29 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.23","vol":"0.57"},{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"0.40","vol":"1.19"},{"date":"2024-09-30","value":"0.31","vol":"0.87"},{"date":"2024-06-30","value":"0.21","vol":"0.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.23 | 0.07 | 0.40 | 0.31 | 0.21 |
| 行业(次) | 0.57 | 0.26 | 1.19 | 0.87 | 0.55 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，居行业前列，两项指标的行业排名分别为 20/72 ， 43/72。
[{"date":"2025-06-30","value":"18.03","vol":"-1392.00"},{"date":"2025-03-31","value":"19.05","vol":"-47.52"},{"date":"2024-12-31","value":"0.27","vol":"-9.01"},{"date":"2024-09-30","value":"29.83","vol":"-29.47"},{"date":"2024-06-30","value":"24.32","vol":"-36875.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.03 | 19.05 | 0.27 | 29.83 | 24.32 |
| 行业 | -1392.00 | -47.52 | -9.01 | -29.47 | -36875.39 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.46","vol":"1.46"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.27","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.05","vol":"2.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.46 | - | 3.27 | - | 3.05 |
| 行业 | 1.46 | 0.00 | 2.00 | 0.00 | 2.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 26/72 ， 24/72。
[{"date":"2025-06-30","value":"3.50","vol":"6.75"},{"date":"2025-03-31","value":"4.32","vol":"7.90"},{"date":"2024-12-31","value":"4.76","vol":"6.83"},{"date":"2024-09-30","value":"4.89","vol":"7.16"},{"date":"2024-06-30","value":"4.82","vol":"7.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.50 | 4.32 | 4.76 | 4.89 | 4.82 |
| 行业 | 6.75 | 7.90 | 6.83 | 7.16 | 7.04 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.23","vol":"5.39"},{"date":"2025-03-31","value":"2.67","vol":"6.47"},{"date":"2024-12-31","value":"3.07","vol":"5.50"},{"date":"2024-09-30","value":"3.26","vol":"5.77"},{"date":"2024-06-30","value":"3.20","vol":"5.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.23 | 2.67 | 3.07 | 3.26 | 3.20 |
| 行业 | 5.39 | 6.47 | 5.50 | 5.77 | 5.91 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 26/72 ， 27/72。
[{"date":"2025-06-30","value":"18.75","vol":"26.08"},{"date":"2025-03-31","value":"16.20","vol":"25.48"},{"date":"2024-12-31","value":"15.94","vol":"25.46"},{"date":"2024-09-30","value":"16.28","vol":"24.92"},{"date":"2024-06-30","value":"16.89","vol":"24.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.75 | 16.20 | 15.94 | 16.28 | 16.89 |
| 行业(%) | 26.08 | 25.48 | 25.46 | 24.92 | 24.62 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.26","vol":"1.11"},{"date":"2025-03-31","value":"0.22","vol":"0.78"},{"date":"2024-12-31","value":"0.22","vol":"0.88"},{"date":"2024-09-30","value":"0.22","vol":"0.41"},{"date":"2024-06-30","value":"0.23","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.26 | 0.22 | 0.22 | 0.22 | 0.23 |
| 行业(%) | 1.11 | 0.78 | 0.88 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 申万宏源 | 2025-07-29 | 买入 | |
| 光大证券 | 2025-07-08 | 增持 | |
| 湘财证券 | 2025-07-03 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"37.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"41.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"45.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.83","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"26.79","blueLineValue":"6.57","type":"YC"}]